The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer (Q33276150)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer
scientific article

    Statements

    The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit